| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/31/2011 | US7951955 Antiviral agents |
| 05/31/2011 | US7951840 Zinc salt compositions for the prevention of dermal and mucosal irritation |
| 05/31/2011 | US7951820 Triazole compounds useful as protein kinase inhibitors |
| 05/31/2011 | US7951386 Recombinant cytochrome oxidase and/or morula membrane protein for use in developing therapeutics which prevent infection associated with mite parasitfes |
| 05/31/2011 | US7951378 Modified cell adhesion molecule comprising immunoglobulin heavy chain fusion for treatment and prevention of respiratory system disorders |
| 05/31/2011 | CA2666674C Feed additive and feed |
| 05/31/2011 | CA2634299C Process for preparing inhibitors of nucleoside metabolism |
| 05/31/2011 | CA2600762C Stable organic peroxide compositions |
| 05/31/2011 | CA2542449C Combined preparation for treating sepsis |
| 05/31/2011 | CA2480470C Inhibitors of nucleoside phosphorylases and nucleosidases |
| 05/31/2011 | CA2475764C New inhibitors of histone deacetylase |
| 05/31/2011 | CA2455635C Use of thiazole derivatives for preparing a medicine for protecting mitochondria |
| 05/31/2011 | CA2451626C One dose vaccination with mycoplasma hyopneumoniae |
| 05/31/2011 | CA2441357C Agent for the prevention and treatment of sexually transmitted diseases-i |
| 05/31/2011 | CA2416566C Depot formulation comprising ceftiofur and peroxidized natural oil |
| 05/31/2011 | CA2398539C Myeloid colony stimulating factor and uses thereof |
| 05/31/2011 | CA2339324C Protein delivery system using human papillomavirus virus-like particles |
| 05/31/2011 | CA2321903C Live recombinant vaccines comprising an adjuvant compound and a viral vector comprising a gene of an animal herpes or influenza virus |
| 05/31/2011 | CA2319080C Multivalent antibacterial agents |
| 05/31/2011 | CA2301942C Molecular mimetics of meningococcal b epitopes |
| 05/31/2011 | CA2215328C Novel human cytomegalovirus dna sequences |
| 05/26/2011 | WO2011063419A2 Lipopeptide compositions and related methods |
| 05/26/2011 | WO2011063263A2 Methods for producing an immune response to tuberculosis |
| 05/26/2011 | WO2011063133A1 LOW ANTIGEN-DOSE IMMUNIZATION FOR MAXIMIZING T-HELPER CELL 1 (T h1) IMMUNITY AGAINST DISEASE |
| 05/26/2011 | WO2011063085A2 Biofilm disruptive compositions |
| 05/26/2011 | WO2011062955A2 Compounds for modulating tlr2 |
| 05/26/2011 | WO2011062592A2 Ds-1/la vie |
| 05/26/2011 | WO2011062263A1 Pharmaceutical composition |
| 05/26/2011 | WO2011062253A1 Novel fused pyrimidine derivative |
| 05/26/2011 | WO2011061849A1 Recombinant measles virus useful as bivalent vaccine against measles and nipah virus infection |
| 05/26/2011 | WO2011061848A1 Recombinant measles virus useful as bivalent vaccine against measles and malaria infection |
| 05/26/2011 | WO2011061747A1 Antifungal and anti parasitic conjugates of amphotericin b derivatives |
| 05/26/2011 | WO2011061667A1 Use of macrocyclic lactone derivatives for the treatment of inflammatory disorders |
| 05/26/2011 | WO2011061590A1 Novel carboxamide derivatives as hiv inhibitors |
| 05/26/2011 | WO2011061476A1 Anti-bacterial treatment and device |
| 05/26/2011 | WO2011061303A1 Quadruple therapy useful for treating persons afflicted with the human immunodeficiency virus (hiv) |
| 05/26/2011 | WO2011061302A1 Novel schedules for administering combination therapies useful for treating persons afflicted with the human immunodeficiency virus (hiv) |
| 05/26/2011 | WO2011061243A1 Heterocyclic antiviral compounds |
| 05/26/2011 | WO2011061237A1 Antimicrobial compositions containing free fatty acids |
| 05/26/2011 | WO2011061236A1 Pharmaceutical compositions comprising an lrp1 receptor agonist for the treatment of cancer and hiv |
| 05/26/2011 | WO2011060976A1 Tryptamine-derived compounds as antibacterial agents |
| 05/26/2011 | WO2011060634A1 23-hydroxy-betulinic acid derivatives, preparation methods and uses thereof |
| 05/26/2011 | WO2011060613A1 Human alpha-defensin 5 mutant polypeptide and preparation method and use thereof |
| 05/26/2011 | WO2011060534A1 Trim5alpha mutants and uses thereof |
| 05/26/2011 | WO2011023830A3 Anti-bacterial compositions comprising extracts of eremophila longifolia and methods for use of same |
| 05/26/2011 | WO2011008092A3 Gram-positive bacteria specific binding compounds |
| 05/26/2011 | WO2011003064A9 Methods of treating neuropathic pain |
| 05/26/2011 | WO2011000566A3 Compounds and pharmaceutical compositions for the treatment of negative-sense ssrna virus infections |
| 05/26/2011 | WO2010144386A3 Antimicrobial polymers |
| 05/26/2011 | WO2010118424A3 Papillomavirus-like particles (vlp) as broad spectrum human papillomavirus (hpv) vaccines |
| 05/26/2011 | US20110126301 Dendritic Cell Marker and Uses Thereof |
| 05/26/2011 | US20110125093 Latex medical articles for release of antimicrobial agents |
| 05/26/2011 | US20110124740 Novel diaryl hepatonoid-based compounds and use thereof |
| 05/26/2011 | US20110124715 Antiviral Oligonucleotides Having a Conserved G4 Core Sequence |
| 05/26/2011 | US20110124707 Methods And Compositions For Reducing Viral Genome Amounts In A Target Cell |
| 05/26/2011 | US20110124703 Molecules comprising a bis(heteroaryl)maleimide backbone, and use thereof in the inhibition of dde/ddd enzymes |
| 05/26/2011 | US20110124702 Nanosuspension of a Poorly Soluble Drug via Microfluidization Process |
| 05/26/2011 | US20110124689 Process for preparing atazanavir bisulfate and novel forms |
| 05/26/2011 | US20110124671 Spiroindenes and spiroindanes as modulators of chemokine receptors |
| 05/26/2011 | US20110124668 Novel indole derivative having, carbamoyl group, ureido group and substituted oxy group |
| 05/26/2011 | US20110124639 3 beta-hydroxysteroid dehydrogenase inhibitors |
| 05/26/2011 | US20110124633 Heterocyclic Compounds, Methods of Making Them and Their Use in Therapy |
| 05/26/2011 | US20110124627 Modulators of toll-like receptors |
| 05/26/2011 | US20110124618 Substituted (pyrazolylcarbonyl)imidazolidinones and their use |
| 05/26/2011 | US20110124598 Chemical compounds |
| 05/26/2011 | US20110124597 Boron containing small molecules |
| 05/26/2011 | US20110124593 Methods for determining chemotherapeutic agents targeting alpha-glucan pathways and uses thereof |
| 05/26/2011 | US20110124592 Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitus c virus |
| 05/26/2011 | US20110124589 Inhaled fosfomycin/tobramycin for the treatment of chronic obstructive pulmonary disease |
| 05/26/2011 | US20110124551 Formulations of daptomycin |
| 05/26/2011 | US20110123646 Extracts Obtained from Cell Line Cultures from Plants Belonging to the Oleaceae Family (e.g. Syringa Vulgaris), Their Preparation and Use |
| 05/26/2011 | US20110123640 Novel fermented milk product and use thereof |
| 05/26/2011 | US20110123632 Nanoscale Adjuvants and Related Pharmaceutical Compositions and Methods |
| 05/26/2011 | US20110123631 Oral compositions of clindamycin |
| 05/26/2011 | US20110123627 High density compositions containing posaconazole and formulations comprising the same |
| 05/26/2011 | US20110123626 Pulmonary delivery of a fluoroquinolone |
| 05/26/2011 | US20110123624 Formulations comprising aminosterols |
| 05/26/2011 | US20110123620 Silicon dioxide nanoparticles and the use thereof for vaccination |
| 05/26/2011 | US20110123619 Buccal delivery system |
| 05/26/2011 | US20110123611 Peptidyl diacylglycerides |
| 05/26/2011 | US20110123608 Pharmaceutical formulation |
| 05/26/2011 | US20110123596 Silica sol material having at least one therapeutically active substance for producing biologically degradable and/or resorbable silica gel materials for human medicine and/or medical technology |
| 05/26/2011 | US20110123591 Tumoricidal, bactericidal, or viricidal macrophage activation |
| 05/26/2011 | US20110123589 Three-dimensional nanocomposite materials consisting of a polysaccharidic matrix and metallic nanoparticles, preparation and use thereof |
| 05/26/2011 | US20110123586 Inhibition of quorum sensing-mediated processes in bacteria |
| 05/26/2011 | US20110123571 Use of bacterium for manufacture of a vaccine |
| 05/26/2011 | US20110123570 Actinobacillus suis antigens |
| 05/26/2011 | US20110123569 Vaccine directed against adenovirus serotype 14 |
| 05/26/2011 | US20110123568 Novel use |
| 05/26/2011 | US20110123565 Structural Proteins of Fish Pancreatic Disease Virus and Uses Thereof |
| 05/26/2011 | US20110123564 Adenoviral-based vectors |
| 05/26/2011 | US20110123560 Infectious Bursal Disease Virus Antigenic Isolates And Vaccines |
| 05/26/2011 | US20110123559 Swine influenza hemagglutinin variants |
| 05/26/2011 | US20110123556 Immunogen prioritization for vaccine design |
| 05/26/2011 | US20110123555 Preparation and utility of ccr5 inhibitors |
| 05/26/2011 | US20110123552 Agonistic binding molecules to the human OX40 receptor |
| 05/26/2011 | US20110123547 Compounds Having CRTH2 Antagonist Activity |
| 05/26/2011 | US20110123546 Compositions Comprising Antibodies or Antibody Fragments |
| 05/26/2011 | US20110123544 Human antibodies that bind human il-12 and methods for producing |
| 05/26/2011 | US20110123536 Novel human anti-r7v antibodies and uses thereof |